Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News TREATWolfram clinical trial to unlock a potential treatment for a rare disease Birmingham is making a real-world impact on rare diseases, with a comprehensive multi-facility network for research helping to find new treatments for patients like those with Wolfram syndrome.
News Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse
News Cancer Research UK Clinical Trials Unit: Celebrating 40 Years of Funding From Cancer Research UK
12 May 2023 Birmingham cancer researchers show how reduced MYB levels promote malignant blood cell development Study showed that low levels of the MYB protein can be linked to the development of rare blood cancers.
10 May 2023 AI-powered personalised medicine tool for hypertension being developed Hypertension patients could receive a personalised medication profile thanks to a new, artificial intelligence-supported research project.
04 May 2023 Incurable blood cancer trial finds new drug better than current second line treatments Cancer Research UK Clinical Trials Unit-sponsored trial found new drug better for treating rare cancer for patients not responding to first line treatment
28 April 2023 Brain cells are starved of energy when autophagy malfunctions, new study finds Research has major implications for neurodegenerative disease treatments
19 April 2023 Drug combination could overcome tumour resistance for some children’s cancers Children with some tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at a conference.
05 April 2023 Birmingham team recognised for showing that blood vessel leakiness can identify brain tumours. A multi-centre trial, led by Professor Andrew Peet, has shown measuring brain tumour blood supply in children can indicate tumours that may be more aggressive.